
Beatrice S. Knudsen MD
Molecular Genetics, Anatomic Pathology, Clinical Pathology
Physician
Join to View Full Profile
8700 Beverly Blvd.,Davis Bldg. 5019Los Angeles, CA 90048
Phone+1 310-248-8687
Fax+1 310-248-6233
Dr. Knudsen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1995 - 1998
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1990
- Weill Cornell MedicineClass of 1989
Certifications & Licensure
- UT State Medical License 2019 - 2026
- CA State Medical License 2012 - 2020
- WA State Medical License 2003 - 2014
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy.Piotr Bialas, Tamae Kobayashi, Rebecka Hellsten, Agnieszka Krzyzanowska, Margareta Persson
The Prostate. 2025-02-01 - 2 citationsONECUT2 is a druggable driver of luminal to basal breast cancer plasticity.Irene Zamora, Mirian Gutiérrez, Alex Pascual, María J Pajares, Miguel Barajas
Cellular Oncology. 2025-02-01 - Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK.Shiela C Samson, Anthony Rojas, Rebecca G Zitnay, Keith R Carney, Wakeiyo Hettinga
Biorxiv. 2024-09-21
Press Mentions
- Deep Bio and ARUP to Conduct a Prospective Study to Evaluate AI Performance in a Real-World Pathology WorkflowOctober 25th, 2021
Grant Support
- Predicting Metastatic Progression of High Risk Localized Prostate CancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2023–2027
- Predicting Metastatic Progression of High Risk Localized Prostate CancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2023–2027
- Pathomics biomarkers for stratification of clear cell kidney cancersUNIVERSITY OF UTAH2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: